Display screen with a graphical user interface
Latest Nurocor, Inc. Patents:
Description
The FIGURE is a front view of a display screen with a graphical user interface.
Claims
The ornamental design for a display screen with a graphical user interface, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
D344102 | February 8, 1994 | Polak |
D502184 | February 22, 2005 | Glezer |
7030890 | April 18, 2006 | Jouet |
D594911 | June 23, 2009 | Hall |
7818689 | October 19, 2010 | Wada |
8286072 | October 9, 2012 | Chamberlain |
D673577 | January 1, 2013 | Cojuangco |
D698361 | January 28, 2014 | Stiffler |
D715834 | October 21, 2014 | Siddons |
D723048 | February 24, 2015 | Helliker |
D732058 | June 16, 2015 | Landis |
D753174 | April 5, 2016 | Cojuangco |
D759072 | June 14, 2016 | Siddons |
D769315 | October 18, 2016 | Scotti |
D771107 | November 8, 2016 | Spector |
D772276 | November 22, 2016 | Yampolskiy |
D788790 | June 6, 2017 | Omata |
D792448 | July 18, 2017 | Take |
D799499 | October 10, 2017 | Selden |
D803248 | November 21, 2017 | Sunshine |
D819687 | June 5, 2018 | Yampolskiy |
D841030 | February 19, 2019 | Bradley-Pollack |
D841031 | February 19, 2019 | Orlando |
D841675 | February 26, 2019 | Hoffman |
D854558 | July 23, 2019 | Melillo |
D855634 | August 6, 2019 | Kim |
D870762 | December 24, 2019 | Mendoza Corominas |
D873846 | January 28, 2020 | Melillo |
D877747 | March 10, 2020 | Belliveau |
D880517 | April 7, 2020 | Imamura |
D881927 | April 21, 2020 | Tsukahara |
D882598 | April 28, 2020 | Belliveau |
10613711 | April 7, 2020 | Makovsky |
D895642 | September 8, 2020 | Hoofnagle |
D900840 | November 3, 2020 | Dudey |
D916869 | April 20, 2021 | Evangeliou |
D922422 | June 15, 2021 | Molander |
D924906 | July 13, 2021 | Nie |
D924909 | July 13, 2021 | Nasu |
D928194 | August 17, 2021 | Baker |
11132552 | September 28, 2021 | Naslavsky |
D937862 | December 7, 2021 | Anderson |
D950580 | May 3, 2022 | Ahmed |
D963677 | September 13, 2022 | Bahatyrevich |
D978887 | February 21, 2023 | Caro |
D980863 | March 14, 2023 | Balsamo |
D985602 | May 9, 2023 | Walecka |
D1040175 | August 27, 2024 | Potash |
D1052603 | November 26, 2024 | Ganapathy |
D1055947 | December 31, 2024 | Harmon |
D1060404 | February 4, 2025 | Arora |
D1061592 | February 11, 2025 | Khokhar |
20050055241 | March 10, 2005 | Horstmann |
20080120574 | May 22, 2008 | Heredia |
20110153358 | June 23, 2011 | Campo et al. |
20130232104 | September 5, 2013 | Goyal et al. |
20140039921 | February 6, 2014 | Broverman et al. |
20150213547 | July 30, 2015 | Gomez-Rosado |
20170075557 | March 16, 2017 | Noble |
20170147794 | May 25, 2017 | Harder |
20170286456 | October 5, 2017 | Wenzel et al. |
20170323320 | November 9, 2017 | Mendoza Corominas |
20180039399 | February 8, 2018 | Kaltegaertner et al. |
20180261305 | September 13, 2018 | Lindblad |
20200335188 | October 22, 2020 | Ozeran |
20200394612 | December 17, 2020 | Khokhar |
20220004540 | January 6, 2022 | Watson et al. |
20220005554 | January 6, 2022 | Malfait et al. |
20220005555 | January 6, 2022 | Malfait et al. |
20220005558 | January 6, 2022 | Malfait et al. |
20230274809 | August 31, 2023 | Dimitrova |
20230360779 | November 9, 2023 | Gnanasambandam et al. |
- Kemegne, Gislaine Aurelie et al., Comparing checkerboard, isobologram and CCD methods for drug combination, Oct. 31, 2021, AcademicJournals.org, retrieved Oct. 24, 2023, https://academicjournals.org/journal/JMPR/article-full-text/C8764D068023 (Year: 2021).
- Dandapandi, Hari G., Leveraging Mobile-Based Sensors for Clinical Research, Jun. 13, 2022, FrontiersIn.org, retrieved Feb. 28, 2025, https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2022.893070/full (Year: 2022).
- Kriebel, Andy, How to Create a Dot Strip Plot, Jun. 8, 2021, YouTube.com, retrieved Feb. 28, 2025, https://www.youtube.com/watch?v=fKSL-IMqILA (Year: 2021).
- “Clinical trials and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http:/www.pharmafile.com/print/511225, Mar. 11, 2016, 6 pp.
- “ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials,” European Medicines Agency, Committee for Medicinal Products for Human Use, EMA/CHMP/CH/4362221/2017, Feb. 17, 2020, 19 pp.
- “Nurocor Clinical Platform—Technical Perspective,” Nurocor, Inc., accessed on Apr. 29, 2020, 11 pp.
- “Optimize Clinical Development,” Nurocor and Intilaris brochure, accessed on Sep. 9, 2020, 2 pp.
- Nelson et al., “CDISC 2019 US Interchange,” [Presentation], CDISC, San Diego, CA, Oct. 14-18, 2019, 19 pp.
- Kountouris et al., “Efficient scheduling of conditional behaviors for high-level synthesis,” ACM Transactions on Design Automation of Electronic Systems, vol. 7, No. 3, Jul. 1, 2002, pp. 380-412.
- Lin et al., “A Standard-Driven Approach for Electric Submission to Pharmaceutical Regulatory Authorities”, Journal of Biomedical Informatics, vol. 79, Jan. 31, 2018, pp. 60-70.
- “Executive Summary—Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate Biopharma, Inc., Nov. 7, 2019, 4 pp.
- “Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate DDF Project Team, TransCelebrate Biopharma, Inc., Nov. 1, 2019, 46 pp.
- “Reusable Asset Specification, Version 2.2,” Object Management Group (OMG), accessed from https://www.omg.org/spec/RAS/2.2/PDF, Nov. 2005, 121 pp.
- Nelson et al., PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC) US Interchange, San Diego, California, Oct. 14-18, 2018, 19 pp.
- “Cost of Developing a New Drug,” Tufts Center for the Study of Drug Development (CSDD), Tufts University, School of Medicine, Nov. 18, 2014, 30 pp.
- “Drug Approval Process—Infographic,” U.S. Food and Drug Administration (FDA), accessed from http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/UCM284393.pdf, accessed on Jan. 20, 2015, 2 pp.
- Burrows, “Report: The 8 biggest challenges facing clinical trail professionals,” Informa Connect, Clinical & Medical Affairs, accessed from https://informaconnect.com/report-biggest-challenges-clinical-trials-pt-1/, Nov. 30, 2016, 4 pp.
- Nelson et al., “3D Standardized in Clinical Development to achieve End-to-End Automation,” Intilaris, Nurocor, 2019 Clinical Data Interchange Standards Consortium (CDISC), Oct. 14-18, 2019, 5 pp.
- “How to avoid costly clinical research delays,” MESM Blog, accessed from https://www.mesm.com/blog/tips-to-help-you-avoid-costly-clinical-research-delays/, dated Jan. 16, 2020, accessed on Mar. 4, 2021, 4 pp.
- Hargreaves, “Clinical trails and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http://www.pharmafile.com/news/511225/clinical-trials-and-their-patients-rising-costs-and-how-stem-loss, Mar. 11, 2016, 8 pp.
- Woodcock et al., “Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both,” Massachusetts Medical Society, The New England Journal of Medicine, Jul. 6, 2017, 9 pp.
- “Nurocor products allow customers to automate clinical development processes from protocol to submission,” NUROCOR Brochure, accessed from www.nurocor.com, accessed on Sep. 10, 2019, 4 pp.
- “Streamline Your Clinical Operations Through Smarter Standardization,” Nurocor, PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC), US Interchange, San Diego, California, Oct. 18, 2019, 22 pp.
- “Facts about Clinical Trials,” Arena International, accessed from https://web.archive.org/web/20180914235739/http://www.arena-international.com/clinicaltrials/facts-about-clinical-trials/1063.article, dated Sep. 14, 2018, accessed on Mar. 4, 2021, 1 pp.
- “Study Data Tabulation Model Implementation Guide: Human Clinical Trials,” Prepared by the CDISC Submission Standards Team, cdisc, Version 3.3 (Final), Clinical Data Interchange Standards Consortium, Inc., Nov. 20, 2018, 426 pp.
- “Biotech Out-Licensed Optimized Compound Value—Product Oriented Licensing Strategy,” Intilaris LifeSciences, accessed on Sep. 9, 2020, 6 pp.
- Ganic et al., “PhUSE EU Connect 2018—Structure and Standardized Study Definition drives early study setup for added business benefits,” Bayer, Intilaris, Nov. 2018, 20 pp.
- Getz et al., “Measuring the Incidence, Causes, and Repercussions of Protocol Amendments,” Therapeutic Innovation and Regulatory Science, Drug Information Journal, vol. 45, Issue 3, May 2011, pp. 265-275.
- Seguine, “Overcoming the Industry's Data Crisis,” Clinical Link, EPC, Aug. 2019, pp. 38-41.
- “The Case for CDISC Standards,” CDISC, Business Case for CDISC Standards, Stage V, Sep. 30, 2014, 45 pp.
- “Information technology—Metadata registries (MDR)—Part 1: Framework,” International Standards, ISO/IEC 11179-1, Second Edition, Sep. 15, 2004, 32 pp.
- “Information technology—Metadata registries (MDR)—Part 2: Classification,” International Standards, ISO/IEC 11179-2, Second Edition, Nov. 15, 2005, 16 pp.
- “Information technology—Metadata registries (MDR)—Part 3: Registry metamodel and basic attributes,” International Standards, ISO/IEC 11179-3, Third Edition, Feb. 15, 2013, 244 pp.
- “Information technology—Metadata registries (MDR)—Part 4: Formulation of data definitions,” International Standards, ISO/IEC 11179-4, Second Edition, Jul. 15, 2004, 16 pp.
- “Information technology—Metadata registries (MDR)—Part 5: Naming principles,” International Standards, ISO/IEC 11179-5, Third Edition, Apr. 1, 2015, 32 pp.
- “Information technology—Metadata registries (MDR)—Part 6: Registration,” International Standards, ISO/IEC 11179-6, Third Edition, Aug. 1, 2015, 72 pp.
- Advisory Action from U.S. Appl. No. 17/305,366 dated Jan. 3, 2025, 2 pp.
- Response to Final Office Action dated Sep. 18, 2024 from U.S. Appl. No. 17/305,368 filed Dec. 17, 2024, 17 pp.
- Response to Final Office Action dated Sep. 28, 2024 from U.S. Appl. No. 17/305,366 filed Nov. 27, 2024, 18 pp.
- Jiang et al., “Using Semantic Web technologies for the generation of domain-specific templates to support clinical study metadata standards”, Journal of Biomedical Semantics, vol. 7, No. 10, BioMed Central, Mar. 6, 2016, 10 pp., https://doi.org/10.1186/s13326-016-0053-5.
- Office Action from U.S. Appl. No. 17/305,366 dated Jan. 29, 2024, 32 pp.
- Response to Office Action dated Jan. 29, 2024 from U.S. Appl. No. 17/305,366 filed May 29, 2024, 21 pp.
- Response to Office Action dated Mar. 8, 2024 from U.S. Appl. No. 17/305,368 filed Jul. 8, 2024, 18 pp.
- Office Action from U.S. Appl. No. 17/305,366 dated Mar. 24, 2025, 28 pp.
- Final Office Action from U.S. Appl. No. 17/305,368 dated Apr. 22, 2025, 16 pp.
- Response to Office Action dated Jan. 6, 2025 from U.S. Appl. No. 17/305,368 filed Apr. 7, 2025, 16 pp.
Patent History
Patent number: D1081702
Type: Grant
Filed: Nov 2, 2020
Date of Patent: Jul 1, 2025
Assignee: Nurocor, Inc. (Austin, TX)
Inventors: Frederik Malfait (Wolfenschiessen), Maurice Williams (Canton, MI), Robert Ross (Lumberton, NJ)
Primary Examiner: Katherine A Holbrow
Assistant Examiner: Christopher M Spivey
Application Number: 29/652,731
Type: Grant
Filed: Nov 2, 2020
Date of Patent: Jul 1, 2025
Assignee: Nurocor, Inc. (Austin, TX)
Inventors: Frederik Malfait (Wolfenschiessen), Maurice Williams (Canton, MI), Robert Ross (Lumberton, NJ)
Primary Examiner: Katherine A Holbrow
Assistant Examiner: Christopher M Spivey
Application Number: 29/652,731
Classifications
Current U.S. Class:
Drop Down Menu Or Full Screen Menu Type (D14/486)